Cyclic RGD Peptides Containing β-Turn Mimetics
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
The α V β 3 -receptor, one member of the integrin family, is implicated in angiogenesis and in human tumor metastasis. Spatial screening led to the highly active first-generation peptide c(RGDfV), which shows a βII‘/γ-turn arrangement with d -Phe in the i + 1 position of the βII‘-turn. Further reduction of the flexibility should be achieved by incorporating different rigid building blocks (turn mimetics) like the ( S )- and ( R )-Gly[ANC-2]Leu dipeptide, the β-turn dipeptide (BTD) and the ( S,S )-spiro-Pro-Leu moiety. These distinct β-turn mimetics are introduced by replacing the d -Phe-Val dipeptide in the lead structure c(RGDfV). In peptide analogues c(RGD“ S -ANC”) ( PA1 ), c(RGD“ R -ANC”) ( PA2 ), and c(RGD“BTD”) ( PA3 ) the turn mimetic does not adopt the desired position in the β-turn, instead Gly occupies the i + 1 position of the βII‘-turn. Only c(RGD“spiro”) PA4 led to the desired βII‘/γ-turn arrangement with the turn motif in the i + 1 and i + 2 position of the β-turn. These effects may arise from particular steric effects of the cyclic pentapeptide system in combination with steric requirements of the ANC and BTD moiety. Additional investigations on cyclic hexapeptide derivatives show that the BTD occupies the expected i + 1 and i + 2 position of a βII‘-turn in these systems. Structure−activity investigations showed that the incorporation of the rigid turn motifs could not reduce the flexibility of the RGD site (ANC and BTD) or fix a conformation which is unable to match the receptor very well (spiro). On the other hand, recent findings that the proton of the amide bond between Asp and the following amino acid is essential for high activity can be confirmed. Moreover, the synthesis of c(RGD“ R -ANC”) PA2 led to one of the compounds most active in inhibiting vitronectin binding to the α V β 3 -integrin.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels
Brooks, P. C., Montgomery, A. M. P., Rosenfeld, M., Reisfeld, R. A., Hu, T., Klier, G., & Cheresh, D. A. (1994) · Cell · doi:10.1016/0092-8674(94)90007-8 · Cited by 2,262
Cited by
Bioactive modification of poly (ethylene glycol) hydrogels for tissue engineering
Zhu, J. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.02.044 · Cited by 1,457
Nicolas, J., Mura, S., Brambilla, D., Mackiewicz, N., & Couvreur, P. (2013) · Chem. Soc. Rev. · doi:10.1039/c2cs35265f · Cited by 1,270
Contemporary strategies for peptide macrocyclization
White, C. J., & Yudin, A. K. (2011) · Nature Chemistry · doi:10.1038/nchem.1062 · Cited by 1,088
Pelay‐Gimeno, M., Glas, A., Koch, O., & Grossmann, T. N. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201412070 · Cited by 717
Mas-Moruno, C., Rechenmacher, F., & Kessler, H. (2010) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152010794728639 · Cited by 647
Self-citation
Metadata
- Authors
- Haubner, R., Schmitt, W., Hölzemann, G., Goodman, S. L., Jonczyk, A., & Kessler, H.
- Venue
- Journal of the American Chemical Society
- Publisher
- American Chemical Society (ACS)
- Published
- 1996-01-01
- Volume
- 118
- Issue
- 34
- Pages
- 7881-7891
- ISSN
- 0002-7863 (ISSN-L)
- 1520-5126
- OpenAlex
- W2071465122
- Cited by
- 135
- References
- 1
- FWCI
- 2.54
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.